misonidazole and Rhabdomyosarcoma
misonidazole has been researched along with Rhabdomyosarcoma in 7 studies
Research
Studies (7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (57.14) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dubois, L; Eriksson, J; Lambin, P; Lieuwes, NG; Peeters, SG; van Dongen, GA; van Elmpt, W; Zegers, CM | 1 |
Bol, A; Bormans, G; Cloetens, L; Dubois, L; Grégoire, V; Haustermans, K; Labar, D; Landuyt, W; Mortelmans, L; Nuyts, J | 1 |
Bormans, G; Dubois, L; Dupont, P; Flamen, P; Haustermans, K; Landuyt, W; Mortelmans, L; Verbeken, E; Vermaelen, P | 1 |
Afzal, SM; Curtis, SB; Tenforde, TS | 1 |
Crabtree, KE; Curtis, SB; Flynn, MJ; Howard, J; Lyman, JT; Parr, SS; Tenforde, SD; Tenforde, TS | 1 |
Afzal, SM; Curtis, SB; Howard, J; Lyman, JT; Parr, SS; Tenforde, TS | 1 |
Reinhold, HS; van den Berg-Blok, A | 1 |
Other Studies
7 other study(ies) available for misonidazole and Rhabdomyosarcoma
Article | Year |
---|---|
A comparative study of the hypoxia PET tracers [¹⁸F]HX4, [¹⁸F]FAZA, and [¹⁸F]FMISO in a preclinical tumor model.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Computer Simulation; Imidazoles; Misonidazole; Models, Biological; Nitroimidazoles; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Triazoles | 2015 |
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model.
Topics: Animals; Autoradiography; Biomarkers; Heart; Hypoxia; Male; Misonidazole; Myocardium; Nitroimidazoles; Positron-Emission Tomography; Rats; Reference Values; Rhabdomyosarcoma; Tissue Distribution | 2009 |
Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry.
Topics: Animals; Antibodies, Monoclonal; Carbonic Anhydrase III; Cell Hypoxia; Fluorodeoxyglucose F18; Heart; Immunoenzyme Techniques; Lung; Male; Misonidazole; Muscles; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rhabdomyosarcoma | 2004 |
Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Topics: Animals; Carbon; Combined Modality Therapy; Ions; Misonidazole; Neon; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Particle Accelerators; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Rats; Relative Biological Effectiveness; Rhabdomyosarcoma | 1984 |
Misonidazole enhancement of radiation-induced growth delay in rat rhabdomyosarcoma tumours exposed to accelerated carbon and neon ions.
Topics: Animals; Carbon; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Nitroimidazoles; Particle Accelerators; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Sarcoma, Experimental | 1981 |
Increased enhancement of tumour response to X-rays and high-LET neon ions by desmethylmisonidazole relative to misonidazole.
Topics: Animals; Dose-Response Relationship, Radiation; Energy Transfer; Misonidazole; Neon; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; X-Rays | 1982 |
Enhancement of thermal damage to the microcirculation of 'sandwich' tumours by additional treatment.
Topics: Animals; Glucose; Hot Temperature; Microcirculation; Misonidazole; Radiation-Sensitizing Agents; Rats; Rats, Inbred Strains; Rhabdomyosarcoma; Sarcoma, Experimental; Time Factors | 1981 |